Facultad de Psicología
Zentrum
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (22)
2024
-
CNS involvement in myotonic dystrophy type 1: does sex play a role?
Frontiers in Neurology , Vol. 15
-
Centenarian hippocampus displays high levels of astrocytic metallothioneins
Aging Cell
2023
-
Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals
Immunity and Ageing, Vol. 20, Núm. 1
-
Executive functions and daily functioning in myotonic dystrophy type 1 ecological assessment with virtual reality
Neuromuscular Disorders, Vol. 33, Núm. 12, pp. 917-922
2022
-
A validated WAIS-IV short-form to estimate intellectual functioning in myotonic dystrophy type 1
Neuromuscular Disorders, Vol. 32, Núm. 9, pp. 749-753
2021
-
Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration
Neuropathology and Applied Neurobiology, Vol. 47, Núm. 7, pp. 1092-1108
2020
-
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study
Journal of Neuropsychology, Vol. 14, Núm. 1, pp. 121-134
-
Neurodegeneration trajectory in pediatric and adult/late DM1: A follow-up MRI study across a decade
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1802-1815
2019
-
Proteolytic Degradation of Hippocampal STEP 61 in LTP and Learning
Molecular Neurobiology, Vol. 56, Núm. 2, pp. 1475-1487
-
Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1
NeuroImage: Clinical, Vol. 24
-
T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians
Aging, Vol. 11, Núm. 22, pp. 10723-10741
2018
-
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old
Frontiers in Aging Neuroscience, Vol. 10
-
Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease
Neurobiology of Disease, Vol. 120, pp. 88-97
2016
-
Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61) levels
Journal of Neurochemistry, Vol. 136, Núm. 2, pp. 285-294
-
SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent
Scientific Reports, Vol. 6
2014
-
Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats
Neuropharmacology, Vol. 79, pp. 726-737
-
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661
-
Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa
Revista de Neurologia, Vol. 58, Núm. 8, pp. 337-344
-
Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys
Molecular Neurobiology, Vol. 50, Núm. 3, pp. 1131-1141
2013
-
Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers
Neurobiology of Aging, Vol. 34, Núm. 5, pp. 1462-1468